Overview

Custodiol Versus Blood Cardioplegaia in Paediatric Cardiac Surgery

Status:
Unknown status
Trial end date:
2020-01-20
Target enrollment:
0
Participant gender:
All
Summary
Cardioplegic arrest is an essential part of cardiac surgery which aims to allow myocardial preservation and minimise myocardial swelling ,while providing a motionless and bloodless field ,.Blood cardioplegia has proven its efficacy for several decades and surgeons are still preferring to use it for myocardial protection of paediatric cardiac surgery ,although it is thought to be more time consuming since it is given with interrupted doses, . Even when advancement has came along the field of myocardial protection and cardioplegia solutions with the introduction of Bretschneider Histidine-Tryptophan-Ketoglutarate solution ,custodiol ,in 1970 ,which is given as a single dose and believed to be convenient, simple to deliver , and less time consuming . Many Surgeons haven't change their practice possibly due to paucity of studies comparing cardioplegia solutions in paediatric cardiac surgery and conflicting reports regarding the superiority of different cardioplegia solution.The investigators aim to provide evidence that will help paediatric cardiac surgeons to choose the optimal solution for their practice .
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Centre, Jeddah
Criteria
Inclusion Criteria:

- All paediatric patients referred to our hospital which will undergo open cardiac
repair with cardiopulmonary bypass and cardioplegic arrest .

Exclusion Criteria:

- All emergency procedure( require immediate surgery)

- Cases that don't require use of cardioplegia .